Filter
16341
Filtered Results: 16341
Text search:
health
for
all
Featured
Recommendations
1370
New Publications
3906
Language
Document type
No document type
8727
Studies & Reports
2762
Guidelines
1920
Manuals
803
Fact sheets
633
Strategic & Response Plan
499
Training Material
327
Situation Updates
213
Infographics
143
Resource Platforms
104
Brochures
89
Online Courses
75
Videos
34
Dashboards/Maps
7
App
5
Countries / Regions
Global
692
India
659
Kenya
408
Sierra Leone
330
South Africa
325
Ethiopia
306
Liberia
298
Nigeria
287
Uganda
278
Nepal
273
Western and Central Europe
252
Latin America and the Carribbean
236
Africa
224
Myanmar / Burma
224
Rwanda
220
Bangladesh
204
Congo, Democratic Republic of
201
Syria
198
Malawi
195
Zambia
195
Tanzania
190
Germany
189
Ukraine
167
Ghana
164
Senegal
152
Philippines
124
Burkina Faso
119
Mozambique
116
Namibia
116
Indonesia
113
Guinea
112
South Sudan
112
Haiti
108
Brazil
107
West and Central Africa
103
Zimbabwe
102
Russia
100
Lesotho
93
Eastern Europe
93
Cambodia
90
Venezuela
89
Yemen
86
East and Southern Africa
85
South–East Asia Region
84
Middle East and North Africa
81
Asia
73
Cameroon
69
Benin
65
Colombia
59
Botswana
59
Mali
51
Afghanistan
48
Eastern Europe and Central Asia
48
Pakistan
45
Eswatini/ Swaziland
43
Central African Republic
41
Côte d’Ivoire / Ivory Coast
40
Madagascar
38
Paraguay
37
Lebanon
37
Somalia
35
Sudan
34
Jordan
32
Peru
31
Vietnam
31
USA
29
China
27
Argentina
27
Thailand
26
Niger
26
Western Pacific Region
26
Angola
24
Iraq
24
Tajikistan
22
Chile
22
Ecuador
20
Turkey
19
Togo
19
North America
19
Moldova
18
Sri Lanka
18
Albania
17
Chad
17
Guinea-Bissau
16
Laos
15
Palestine
14
Georgia
14
Spain
13
Bolivia
13
Iran
12
Burundi
12
Papua New Guinea
12
Libya
12
Mexico
11
Kazakhstan
11
Italy
11
United Kingdom
11
Portugal
10
Egypt
10
North Macedonia
9
Greece
9
Kyrgyzstan
8
Southern Africa
8
Switzerland
7
Timor Leste/ East Timor
7
El Salvador
7
Gambia
7
Singapore
7
Armenia
7
Jamaica
7
Romania
7
Poland
7
Bhutan
7
Serbia
6
Malaysia
6
Hungary
6
Saudi Arabia
6
Morocco
5
Ireland
5
Turkmenistan
5
France
5
Honduras
5
Guatemala
5
Canada
4
Fiji
4
Congo-Brazzaville
4
Uzbekistan
4
Dominican Republic
4
Japan
4
Tunisia
4
Australia
3
Estonia
3
Vanuatu
3
Mongolia
3
Croatia
3
Gabon
3
Mauritius
3
Azerbaijan
3
Belarus
3
Bosnia and Herzegovina
3
Nicaragua
3
Djibouti
3
North Korea
2
Austria
2
Qatar
2
Bulgaria
2
Mauritania
2
Lithuania
2
South Korea
2
French Guyana
2
Israel
2
Slovakia
2
Solomon Islands
2
Cape Verde
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Algeria
1
Morocco
1
Latvia
1
Oman
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
5951
Clinical Guidelines
1026
Key Resources
882
Women & Child Health
778
Public Health
742
Capacity Building
358
Pharmacy & Technologies
153
Annual Report MEDBOX
3
Toolboxes
COVID-19
1823
Mental Health
1278
HIV
1048
TB
734
Disability
620
Planetary Health
594
Ebola & Marburg
578
NTDs
483
Caregiver
468
Conflict
460
Rapid Response
439
Refugee
439
AMR
402
NCDs
318
Global Health Education
279
Pharmacy
257
Natural Hazards
225
Health Financing Toolbox
221
Malaria
138
Zika
128
Cholera
123
Polio
90
Specific Hazards
89
Social Ethics
81
Typhoon
11
South Sudan
2
17 February 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an ...
Persons with acute respiratory illness with sudden onset of at least one of the following: cough, sore throat, shortness of breath or fever [≥ 38°C (measured) or history of fever (subjective)] irrespective of admission status AND In the 14 days prior to onset of symptoms, met at least one of the ...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Report for WHO Meningitis guideline revision
Dr Thomas Waite, April 2014
Field Epidemiology Services, Public Health England; UK
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
The document introduces a simple classification, minimums standards and a registration form for Foreign Medical Teams (FMTs) that may provide surgical and trauma care arriving within the aftermath of a sudden onset disaster. These can serve as tools to improve the coordination of the foreign medical...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal...
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will help countries, regions, provinces or cities intendi...
THIS LEAFLET AIMS AT GUIDING YOU THROUGH THE VERY FIRST DAYS OF AN OUTBREAK
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
Interim Guidance 18th March 2020
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
This guide highlights actions health professionals can take to make the Arms Trade Treaty effective.
The Government of India is embarking on a mammoth task to prevent COVID-19 spread among communities. The Rapid Evidence Synthesis team received a request to support the planning and development of resources for ensuring preparedness of FLHWs for COVID-19 . The rapid evidence synthesis was conducted ...
